Company Intelligence Profile

API Holdings Limited

API Holdings Limited is the unlisted Mumbai-based public holding company behind PharmEasy, India's largest digital healthcare aggregator by GMV; incorporated 2019, ~$1.19B raised, ~Rs 5,664 cr consolidated FY24 revenue, majority owner of listed Thyrocare Technologies.

CIN: U60100MH2019PLC323444ActiveRoC-MumbaiConfidence: high

Last updated 6 September 2026

AI OverviewGenerated from public records

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about API Holdings

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Confirmed
Registered nameAPI Holdings Limited
CINU60100MH2019PLC323444
PANAASCA1201E. Source: Tofler; corroborated by GST record (GSTIN embeds this PAN).
Status
  • Active — Unlisted Public Company (limited by shares)
  • Source: Tofler, TheCompanyCheck
Listing
  • Unlisted (public limited but not listed on any stock exchange)
  • Shares trade in the unlisted/pre-IPO grey market
  • Subsidiary Thyrocare Technologies Ltd is separately listed on NSE/BSE
  • Source: Tofler, multiple unlisted-share platforms
Incorporated31 March 2019. Source: Tofler, TheCompanyCheck (both agree).
ROC
  • RoC-Mumbai (Maharashtra)
  • Source: TheCompanyCheck, Tofler
Sector (NIC)
  • Classified under "Transport and Storage" (services incidental to land/water/air transportation, wholesale trading) per RoC NIC classification on Tofler — a legacy/holding-company classification
  • Actual business is digital healthcare/e-pharmacy aggregation
  • Exact NIC code not obtained
Registered address
  • CONFLICT across sources: (a) Tofler: "1st Floor, E-Shape Building, Ashok Silk Mills Compound, 202, L.B.S Marg, Ghatkopar (West), Mumbai, Maharashtra 400086" (likely current)
  • (b) TheCompanyCheck: "D-37/1 TTC MIDC Industrial Area, Turbhe, Navi Mumbai, Thane, Maharashtra 400703"
  • Both are Maharashtra addresses; reported as-is
Authorized capital
  • Rs 3,500 crore
  • Source: Tofler and TheCompanyCheck (agree)
  • Note: Rs 3,500 cr rights issue was reported oversubscribed (Oct 2023, Business Standard)
Paid-up capitalCONFLICT: Tofler shows Rs 700.44 crore; treat as approximately Rs 700-740 crore.

Business Overview

Confirmed
  • API Holdings Limited is the parent/holding company of PharmEasy, India's largest digital healthcare aggregator by GMV (founded 2015, Mumbai-HQ)
  • Core offerings: online pharmacy marketplace (medicine delivery); tech-enabled hospital supplies and pharma distribution (B2B connecting pharmacies with wholesalers/pharma companies); diagnostics
  • EMR & clinic practice-management software; teleconsultation
  • Business model has historically been loss-making with operating expenses exceeding revenue
  • Source: multiple

Directors & KMP

Partial / conflicting
NameDINRoleAppointed
Siddharth Bhaskar Shah05186193Managing Director-
Rahul Franklin Guha09588432Managing Director-
Dhaval Shah07485688Whole-time Director-
Vineeta Rai07013113Director-
Subramaniam Somasundaram (01494407--

GST Registrations

Confirmed
GSTINStatePANStatus
27AASCA1201E1Z3MaharashtraAASCA1201E. Source: Tofler; corroborated by GST record (GSTIN embeds this PAN).Active

Primary GSTIN: 27AASCA1201E1Z3 (Maharashtra — home state, state code 27). PAN: AASCA1201E. Registration date: 25 September 2019. Taxpayer type: Regular. Status: Active. Number of registrations under this PAN: 5 (Maharashtra, Karnataka, Delhi, West Bengal, Telangana per KnowYourGST). CAVEAT: GST legal name still reads "API HOLDINGS PRIVATE LIMITED" (stale pre-conversion name; same PAN/entity). Source: KnowYourGST, Masters India.

Financials

Partial / conflicting
  • CONSOLIDATED (group): FY2024 total revenue approx Rs 5,664 crore, down ~14.7% from FY2023's approx Rs 6,644 crore (Rs 66,439.38 mn)
  • Structurally loss-making — FY23 total expenses approx Rs 8,065 cr vs revenue Rs 6,644 cr
  • FY24 loss reduced YoY but exact FY24 consolidated PAT/net loss, EBITDA, net worth and borrowings NOT reliably obtained (single web-search source; annual-report PDF could not be parsed)
  • STANDALONE: operating revenue range "Over Rs 500 cr", revenue -21.32% YoY, borrowings -49.4%, net worth +37.75%; exact standalone figures behind Tofler Pro paywall
  • Report distinguishes standalone vs consolidated; precise audited line items marked not obtained rather than invented

Funding

Confirmed
  • Total raised approx $1.19 billion across ~6 rounds from 67 investors
  • Latest: Series F, 29 April 2024, $216M led by Manipal Education & Medical Group (MEMG, ~Rs 800 cr); other participants Prosus (~Rs 221 cr), 360 One (~Rs 200 cr), Temasek (~Rs 183 cr), and CDPQ/WSSS/Goldman Sachs/Evolution Debt Capital (~Rs 400 cr cumulatively)
  • This round came at ~$710M valuation — a ~90% drop from the 2021 peak of ~$5.6B. Source: Entrackr, YourStory, Tracxn

In the News

Confirmed
  • API Holdings takes 51% of Thyrocare via Docon merger

    Dealroom · 13 days ago

  • API Holdings acquires 51% stake in Thyrocare via amalgamation scheme

    scanx.trade · 13 days ago

  • API Holdings - 2026 Funding Rounds & List of Investors

    Tracxn · 17 days ago

  • API Holdings Clears ₹1,050 Cr Debt, Unpledges Thyrocare Stake

    BW Healthcare World · a month ago

  • API Holdings Turns Debt-Free — Repays ₹1,050 Crore, Frees Thyrocare Shares from Pledge

    TheWire.in · a month ago

Headlines about API Holdings Limited reported by third-party publications. Recur Club does not author or endorse this coverage. Last checked 11 days ago.

Source: Google News aggregated headlines

Shareholding

Partial / conflicting
  • Institutional/PE-backed, unlisted
  • Key investors include Prosus/Naspers, Temasek, TPG, CDPQ, MEMG (Manipal), 360 One, Goldman Sachs, Evolution Debt Capital, WSSS Investments
  • Tracxn cites ~48 institutional + ~19 angel investors
  • Detailed percentage cap table not obtained
  • Founders include Siddharth Shah, Dhaval Shah, Dharmil Sheth
  • Source: Entrackr, Tracxn

Charges & Loans

Partial / conflicting
  • Tofler reported "no registered charges identified." However, given large borrowings historically (incl. Goldman Sachs debt) this is likely incomplete/paywalled — treat as partial, not confirmed
  • Detailed charge register (charge holders, amounts, dates) not obtained

Competitors

Confirmed
Tata 1mg
Tata Digital
Netmeds
Reliance/JioMart
Apollo 24/7 / Apollo Pharmacy
Apollo Hospitals
MediBuddy
mid
Practo
mid, teleconsult

Frequently Asked Questions

What does API Holdings Limited do?
API Holdings Limited is the unlisted Mumbai-based public holding company behind PharmEasy, India's largest digital healthcare aggregator by GMV; incorporated 2019, ~$1.19B raised, ~Rs 5,664 cr consolidated FY24 revenue, majority owner of listed Thyrocare Technologies.
What is the CIN of API Holdings Limited?
The Corporate Identification Number (CIN) of API Holdings Limited is U60100MH2019PLC323444.
Where is API Holdings Limited registered?
API Holdings Limited is registered with RoC-Mumbai (Maharashtra). Source: TheCompanyCheck, Tofler.. Registered address: CONFLICT across sources: (a) Tofler: "1st Floor, E-Shape Building, Ashok Silk Mills Compound, 202, L.B.S Marg, Ghatkopar (West), Mumbai, Maharashtra 400086" (likely current). (b) TheCompanyCheck: "D-37/1 TTC MIDC Industrial Area, Turbhe, Navi Mumbai, Thane, Maharashtra 400703". Both are Maharashtra addresses; reported as-is..

Explore on Recur Club

Bharat Ke Super Founders

Recur Club's show spotlighting the founders building India's next generation of companies. Watch their stories.

Watch the show

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.